Superior, Colorado
United States
21
2026-03-19
The entities that hold a legal rights for patent applications filed by inventor REN Li:
Li REN from Superior, US has applied for patents for these inventions. The list has both pending applications and granted patents:
POLYCYCLIC QUINAZOLINES FOR INHIBITION OF ERBB2
#2 | 2025-08-213,4-DIHYDRO-2,7-NAPHTHYRIDINE-1,6(2H,7H)-DIONES AS MEK INHIBITORS
#3 | 2025-07-31COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS
#4 | 2025-07-245- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES
#5 | 2025-05-01ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2
#6 | 2024-08-29NAPHTHYRIDONE COMPOUNDS FOR INHIBITION OF RAF KINASES AND/OR BCR-ABL TYROSINE KINASES
#7 | 2024-07-11SULFONE- AND SULFOXIMINE-BASED SELECTIVE PARP1 INHIBITORS
#8 | 2024-04-11LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2
#9 | 2024-02-087-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES
#10 | 2024-01-043,4-DIHYDRO-2,7-NAPHTHYRIDINE-1,6(2H,7H)-DIONES AS MEK INHIBITORS
#11 | 2023-11-30FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2
#12 | 2023-11-305- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases
#13 | 2023-05-25Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2
#14 | 2023-04-275- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases
#15 | 2023-04-203,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors
#16 | 2023-03-025- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases
#17 | 2022-10-133,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors
#18 | 2022-09-15Compounds for the treatment of BRAF-associated diseases and disorders
#19 | 2022-09-15Compounds for the treatment of BRAF-associated diseases and disorders
#20 | 2020-12-31Compounds for the treatment of BRAF-associated diseases and disorders
#21 | 2007-03-01Raf inhibitor compounds and methods of use thereof
2949337 ⎘